Adamczak Łukasz, Mantaj Urszula, Klupczyńska-Gabryszak Agnieszka, Plewa Szymon, Gutaj Paweł, Matysiak Jan, Wender-Ożegowska Ewa
Department of Reproduction, Chair of Fetomaternal Medicine, Poznań University of Medical Sciences, Poznań, Poland.
Doctoral School, Poznań University of Medical Sciences, Poznań, Poland.
Med Sci Monit. 2025 Jun 6;31:e948047. doi: 10.12659/MSM.948047.
BACKGROUND This study aimed to compare amino acid concentrations in pregnant patients with obesity and gestational diabetes mellitus (GDM) to those in healthy pregnant women at different stages of pregnancy. MATERIAL AND METHODS The study group consisted of 50 pregnant women with obesity (body mass index [BMI] >30 kg/m²) diagnosed with GDM in the first half of pregnancy. The control group included 25 healthy pregnant women with a BMI <25 kg/m². Blood samples were collected at visit V1 (no later than 20 weeks of gestation) and V2 (between weeks 37 and 39). The amino acid profiles were determined using a hybrid triple quadrupole/linear ion trap mass spectrometer coupled with a liquid chromatography instrument. RESULTS Of the 30 measured amino acids, 23 serum concentrations differed significantly in patients with obesity. Proline (P<0.001), leucine (P=0.001), valine (P=0.001), and isoleucine (P=0.001) were higher in the obesity group than the control group. Conversely, glutamine (P=0.001), taurine (P=0.008), and asparagine (P=0.001) were significantly lower in obesity group than control group during both observation periods. Changes in isoleucine (P=0.023), tyrosine (P=0.011), taurine (0.032), and phenylalanine (P=0.009) concentrations were associated with patients' weight gain during pregnancy. CONCLUSIONS Research on amino acids offers a detailed understanding of the metabolic interactions that play a crucial role. Metabolomics has emerged as a technology with significant potential for early detection of GDM and for enhancing our understanding of the pathogenesis and impact of the disease on both the mother and her offspring.
背景 本研究旨在比较肥胖合并妊娠期糖尿病(GDM)的孕妇与健康孕妇在妊娠不同阶段的氨基酸浓度。
材料与方法 研究组由50例在妊娠前半期被诊断为GDM的肥胖孕妇(体重指数[BMI]>30kg/m²)组成。对照组包括25例BMI<25kg/m²的健康孕妇。在V1访视(妊娠不超过20周)和V2访视(妊娠37至39周之间)采集血样。使用与液相色谱仪联用的混合三重四极杆/线性离子阱质谱仪测定氨基酸谱。
结果 在测定的30种氨基酸中,肥胖患者的23种血清浓度有显著差异。肥胖组的脯氨酸(P<0.001)、亮氨酸(P=0.001)、缬氨酸(P=0.001)和异亮氨酸(P=0.001)高于对照组。相反,在两个观察期内,肥胖组的谷氨酰胺(P=0.001)、牛磺酸(P=0.008)和天冬酰胺(P=0.001)均显著低于对照组。异亮氨酸(P=0.023)、酪氨酸(P=0.011)、牛磺酸(0.032)和苯丙氨酸(P=0.009)浓度的变化与患者孕期体重增加有关。
结论 对氨基酸的研究有助于深入了解起关键作用的代谢相互作用。代谢组学已成为一项具有巨大潜力的技术,可用于早期检测GDM,并增进我们对该疾病发病机制及其对母亲和后代影响的理解。